🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michele Del Vecchio

Fondazione IRCCS Istituto Nazionale dei Tumori

ORCID: 0000-0001-9060-2512

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “1074P Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile”.

1074P Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1459

N/A

0DataRank · unranked

2 citations

Anna Maria Di Giacomo, Pietro Quaglino, V. Chiarion Sileni, Paola Queirolo, Federica De Galitiis +15 more

Association of circulating tumor DNA kinetics with disease recurrence in patients with stage IIIB/C/IV melanoma treated with adjuvant immunotherapy in Checkmate 238.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9577

N/A

0DataRank · unranked

6 citations

Jennifer Wiggins, Josephine Alegun, Saim Ali, Hao Tang, Sheen Wang +10 more

Data from Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells

(2023)10.1158/1078-0432.c.6517764

N/A

0DataRank · unranked

0 citations

Michele Del Vecchio, Barbara Savoldo, Valentina Hoyos, Aurélie Dutour, Andrea Anichini +3 more